Denmark · pharma & biotech
Pharmaceutical Cold Storage in Denmark — Planning, Capacity and Suppliers
Denmark concentrates an unusually large share of Europe's biologics and insulin manufacturing in a small country, which means most Danish pharma cold storage projects are expansions on constrained sites rather than greenfield builds. This page covers the design conditions, redundancy expectations and cost drivers that shape those projects before suppliers quote.
Direct answers for project buyers
Pharmaceutical cold storage in Denmark is planned around a mild maritime ambient (roughly 26–28 °C summer design), a strong and largely decarbonised grid, high labour and installation cost, and a supplier base that expects a documented specification. Typical projects are +2/+8 °C validated rooms attached to existing manufacturing or distribution sites, increasingly with −20 °C and −80 °C zones for biologics and clinical trial material.
The market in context
Planning parameters
- Summer ambient design
- ≈ 26–28 °C dry bulb; plant-room condition often the binding constraint
- Electricity (commercial, indicative)
- ≈ EUR 0.13–0.22 / kWh — model the range, not a point value
- Typical bands
- +15/+25 °C CRT, +2/+8 °C, −20 °C, −70/−80 °C for biologics and trial material
- Redundancy norm
- N+1 minimum on critical rooms; 2N seen on high-value biologics
- Cost note
- Equipment near EU average; installation labour above it — favour prefabricated plant
- Value option
- Heat recovery into district heating — request as a separately priced line
Direct answers for project buyers
How do you size a pharmaceutical cold room for a Danish site?
Build the load from envelope transmission at the local summer design condition, product pull-down for the daily intake at its real entry temperature, door and airlock infiltration, and internal gains, then divide by the design running hours and apply the redundancy factor. On a Danish retrofit, check the result against available electrical capacity and plant-room space before it goes into the RFQ — a duty the site cannot power is not a duty.
What redundancy is expected on Danish biologics storage?
N+1 refrigeration with automatic changeover is the practical minimum on rooms holding product that cannot be replaced, with a standby generator and UPS on controls and monitoring. High-value biologics sites frequently go to 2N or to fully separated systems per room. The level is a risk decision for the operator, but it must be fixed before quoting because it moves both cost and plant-room footprint substantially.
Retrofit or a new plant on a Danish site?
Retrofit wins where the envelope is sound and the constraint is capacity or efficiency; a new plant wins where the refrigerant is being phased out, the controls cannot support modern monitoring, or the room's uniformity cannot be brought inside the band. Model both against ten-year running cost rather than purchase price — Danish electricity prices make the energy line decisive.
Typical project scale
- Validated suite inside an existing GMP site: 50–300 m²
- Regional distribution store: 300–2,000 m² multi-band
- Biologics campus zone: 2,000 m²+ with −20 °C and ULT areas
How this project is usually structured
- 1Denmark
- 2Pharma / biotech manufacturing or distribution site
- 3+2/+8 °C validated storage (with −20 °C / ULT zones)
- 4Industrial refrigeration plant, N+1
- 5Cooling load + energy + TCO calculators
- 6Structured pharmaceutical RFQ
Tools for this project
How ColdMatch Group works — independent B2B procurement and sourcing platform — ColdMatch Group is an independent B2B procurement and sourcing platform for industrial refrigeration, cold storage and cold-chain projects from USD $250K+, connecting buyers with qualified third-party suppliers, EPC contractors and independent financing providers.
References
ColdMatch Group is a B2B procurement platform. It provides planning tools and connects project buyers with relevant manufacturers and solution providers. It is not a manufacturer, engineering contractor, validation consultant or certification body, and nothing on this page is regulatory or validation advice.
